BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24917455)

  • 21. Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.
    Johnston C; Zhu J; Jing L; Laing KJ; McClurkan CM; Klock A; Diem K; Jin L; Stanaway J; Tronstein E; Kwok WW; Huang ML; Selke S; Fong Y; Magaret A; Koelle DM; Wald A; Corey L
    J Virol; 2014 May; 88(9):4921-31. PubMed ID: 24554666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
    Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
    Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation.
    Zhu J; Koelle DM; Cao J; Vazquez J; Huang ML; Hladik F; Wald A; Corey L
    J Exp Med; 2007 Mar; 204(3):595-603. PubMed ID: 17325200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization.
    Gallichan WS; Rosenthal KL
    J Infect Dis; 1998 May; 177(5):1155-61. PubMed ID: 9592997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes.
    Laing KJ; Magaret AS; Mueller DE; Zhao L; Johnston C; De Rosa SC; Koelle DM; Wald A; Corey L
    J Clin Immunol; 2010 Sep; 30(5):703-22. PubMed ID: 20635156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa.
    Chan T; Barra NG; Lee AJ; Ashkar AA
    J Reprod Immunol; 2011 Mar; 88(2):210-8. PubMed ID: 21334750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpes.
    Braun RP; Payne LG; Dong L
    Virol J; 2006 Jul; 3():54. PubMed ID: 16822314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infection.
    Johnson AJ; Nelson MH; Bird MD; Chu CF; Milligan GN
    J Reprod Immunol; 2010 Jan; 84(1):8-15. PubMed ID: 19942296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue-resident T cell-derived cytokines eliminate herpes simplex virus-2-infected cells.
    Roychoudhury P; Swan DA; Duke E; Corey L; Zhu J; Davé V; Spuhler LR; Lund JM; Prlic M; Schiffer JT
    J Clin Invest; 2020 Jun; 130(6):2903-2919. PubMed ID: 32125285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathological effect of IL-17A-producing TCRγδ(+) T cells in mouse genital mucosa against HSV-2 infection.
    Kim JO; Cha HR; Kim ED; Kweon MN
    Immunol Lett; 2012 Sep; 147(1-2):34-40. PubMed ID: 22698680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homing in on the cellular immune response to HSV-2 in humans.
    Koelle DM; Gonzalez JC; Johnson AS
    Am J Reprod Immunol; 2005 Apr; 53(4):172-81. PubMed ID: 15760378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral blood CD4 T-cell and plasmacytoid dendritic cell (pDC) reactivity to herpes simplex virus 2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes.
    Moss NJ; Magaret A; Laing KJ; Kask AS; Wang M; Mark KE; Schiffer JT; Wald A; Koelle DM
    J Virol; 2012 Sep; 86(18):9952-63. PubMed ID: 22761381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
    Awasthi S; Mahairas GG; Shaw CE; Huang ML; Koelle DM; Posavad C; Corey L; Friedman HM
    J Virol; 2015 Aug; 89(16):8497-509. PubMed ID: 26041292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challenge.
    Çuburu N; Wang K; Goodman KN; Pang YY; Thompson CD; Lowy DR; Cohen JI; Schiller JT
    J Virol; 2015 Jan; 89(1):83-96. PubMed ID: 25320297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2.
    Zhao X; Deak E; Soderberg K; Linehan M; Spezzano D; Zhu J; Knipe DM; Iwasaki A
    J Exp Med; 2003 Jan; 197(2):153-62. PubMed ID: 12538655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice.
    Harandi AM; Svennerholm B; Holmgren J; Eriksson K
    J Gen Virol; 2001 Apr; 82(Pt 4):845-853. PubMed ID: 11257190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8
    Lopes PP; Todorov G; Pham TT; Nesburn AB; Bahraoui E; BenMohamed L
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seminal vesicle fluid increases the efficacy of intravaginal HSV-2 vaccination.
    Varese A; Remes Lenicov F; Gonzalez Prinz M; Paletta A; Ernst G; Maeto C; Merlotti A; Sabatte J; Símula S; Holgado MP; Dantas E; Geffner J; Ceballos A
    Mucosal Immunol; 2018 Mar; 11(2):536-548. PubMed ID: 28745327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective immunity to genital herpes simplex [correction of simpex] virus type 2 infection is mediated by T-bet.
    Svensson A; Nordström I; Sun JB; Eriksson K
    J Immunol; 2005 May; 174(10):6266-73. PubMed ID: 15879125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological Inhibition of IRE-1 Alpha Activity in Herpes Simplex Virus Type 1 and Type 2-Infected Dendritic Cells Enhances T Cell Activation.
    Tognarelli EI; Retamal-Díaz A; Farías MA; Duarte LF; Palomino TF; Ibañez FJ; Riedel CA; Kalergis AM; Bueno SM; González PA
    Front Immunol; 2021; 12():764861. PubMed ID: 35069537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.